v3.26.1
UNEARNED INCOME (Details Narrative) - Oncology Pharma Inc [Member]
Apr. 07, 2021
USD ($)
shares
Defined Benefit Plan Disclosure [Line Items]  
Nonrefundable fee receivable $ 55,000
Royalties percentage based on net sales 5.00%
Consideration percentage 10.00%
Fair value of stock and cash prepaid $ 1,850,000
KCL Therapeutics Inc [Member]  
Defined Benefit Plan Disclosure [Line Items]  
Royalties percentage based on net sales 5.00%
Consideration percentage 10.00%
Shares issuable for nonrefundable fee | shares 50,000
Fair value of stock and cash prepaid $ 55,000